CombinatoRx, Incorporated
CombinatoRx to Present Data for Oncology Programs at American Association for Cancer Research Meeting
Published in Hematology Week, April 26th, 2010
CombinatoRx, Incorporated (NASDAQ: CRXX) announced that preclinical data on its discovery of novel synergistic drug combinations for the treatment of cancer will be highlighted at the 101st Annual meeting of the American Association for Cancer Research 2010, April 17-21, in Washington, DC. These preclinical studies reinforce the rationale for investigation of A2A and b2AR agonists in the treatment of multiple myeloma and other B-cell malignancies and highlight the power of the CombinatoRx combination high throughput screening (cHTS™) technology to interrogate combination activity across large panels of cancer cells to identify novel mechanisms for therapeutic application. Poster...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2010-04-26)
More Articles from Hematology Week
- Louisiana State University Health Sciences Center
Research discovery may lead to advances in heart disease and cancer treatment - National Institute on Deafness
Traditional 'heel stick' test is not an effective screening tool for CMV in newborns - Research
Small molecule targets B cell lymphoma - World Journal of Gastroenterology
Leukemia-related protein 16 and colorectal carcinoma - Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals Announces the Initiation of a Second Study of AEOL 10150 as a Medical Countermeasure for GI Acute Radiation Syndrome Funded by the National Institutes of Health's National Institute for Allergy and Infectious Diseases - Alpha-thalassemia
Kaohsiung Medical University Hospital publishes research in alpha-thalassemia - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
